The pathology of multiple sclerosis.

[1]  Ichiro Nakashima,et al.  A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis , 2004, The Lancet.

[2]  M. Barnett,et al.  Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesion , 2004, Annals of neurology.

[3]  S. Weigand,et al.  Change in MS-related disability in a population-based cohort , 2004, Neurology.

[4]  K. Jellinger,et al.  Expression of Major Histocompatibility Complex class l Molecules on the Different Cell Types in Multiple Sclerosis Lesions , 2004, Brain pathology.

[5]  R. Reynolds,et al.  Molecular Changes in Normal Appearing White Matter in Multiple Sclerosis are Characteristic of Neuroprotective Mechanisms Against Hypoxic Insult , 2003, Brain pathology.

[6]  H. Ulmer,et al.  Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event. , 2003, The New England journal of medicine.

[7]  H. Lassmann.  Axonal injury in multiple sclerosis , 2003, Journal of neurology, neurosurgery, and psychiatry.

[8]  H. Neumann.  Molecular mechanisms of axonal damage in inflammatory central nervous system diseases. , 2003, Current opinion in neurology.

[9]  K. Jellinger,et al.  Preferential Loss of Myelin‐Associated Glycoprotein Reflects Hypoxia‐Like White Matter Damage in Stroke and Inflammatory Brain Diseases , 2003, Journal of neuropathology and experimental neurology.

[10]  Hans Lassmann,et al.  Hypoxia-like tissue injury as a component of multiple sclerosis lesions , 2002, Journal of the Neurological Sciences.

[11]  P. Matthews,et al.  Thalamic neurodegeneration in multiple sclerosis , 2002, Annals of neurology.

[12]  C. Brosnan,et al.  Multiple sclerosis: Re-expression of a developmental pathway that restricts oligodendrocyte maturation , 2002, Nature Medicine.

[13]  S. Perlman,et al.  Bystander CD8 T Cell-Mediated Demyelination After Viral Infection of the Central Nervous System1 , 2002, The Journal of Immunology.

[14]  Hans Lassmann,et al.  A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. , 2002, Brain : a journal of neurology.

[15]  H. Neumann,et al.  Cytotoxic T lymphocytes in autoimmune and degenerative CNS diseases , 2002, Trends in Neurosciences.

[16]  A. Ziegler,et al.  Oligoclonal expansion of memory CD8+ T cells in cerebrospinal fluid from multiple sclerosis patients. , 2002, Brain : a journal of neurology.

[17]  R. Rudick,et al.  Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. , 2002, The New England journal of medicine.

[18]  H. Lassmann,et al.  The Membrane Attack Complex of Complement Causes Severe Demyelination Associated with Acute Axonal Injury1 , 2002, The Journal of Immunology.

[19]  J. Goverman,et al.  A Pathogenic Role for Myelin-Specific Cd8+ T Cells in a Model for Multiple Sclerosis , 2001, The Journal of experimental medicine.

[20]  B. Trapp,et al.  Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions , 2001, Annals of neurology.

[21]  H. Yoshikawa,et al.  Myelin-associated oligodendrocytic basic protein modulates the arrangement of radial growth of the axon and the radial component of myelin , 2001, Medical Electron Microscopy.

[22]  R. Franklin,et al.  Macrophage depletion impairs oligodendrocyte remyelination following lysolecithin‐induced demyelination , 2001, Glia.

[23]  A. Dinçer,et al.  Baló's concentric sclerosis: clinical and radiologic features of five cases. , 2001, AJNR. American journal of neuroradiology.

[24]  H. Wekerle,et al.  Myelin Antigen-Specific CD8+ T Cells Are Encephalitogenic and Produce Severe Disease in C57BL/6 Mice1 , 2001, The Journal of Immunology.

[25]  Kenneth J. Smith,et al.  Electrically active axons degenerate when exposed to nitric oxide , 2001, Annals of neurology.

[26]  J. Dehmeshki,et al.  Magnetisation transfer ratio histogram analysis of primary progressive and other multiple sclerosis subgroups , 2001, Journal of the Neurological Sciences.

[27]  C. Lucchinetti,et al.  Multiple Sclerosis: Current Pathophysiological Concepts , 2001, Laboratory Investigation.

[28]  C. Lucchinetti,et al.  Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy. , 2001, Trends in molecular medicine.

[29]  R Hohlfeld,et al.  The ups and downs of multiple sclerosis therapeutics , 2001, Annals of neurology.

[30]  R. Rudick,et al.  Neurological disability correlates with spinal cord axonal loss and reduced N‐acetyl aspartate in chronic multiple sclerosis patients , 2000, Annals of neurology.

[31]  C Confavreux,et al.  Relapses and progression of disability in multiple sclerosis. , 2000, The New England journal of medicine.

[32]  G J Barker,et al.  The effect of interferon beta-1b treatment on MRI measures of cerebral atrophy in secondary progressive multiple sclerosis. European Study Group on Interferon beta-1b in secondary progressive multiple sclerosis. , 2000, Brain : a journal of neurology.

[33]  Ludwin Sk,et al.  The neuropathology of multiple sclerosis. , 2000 .

[34]  Hans Lassmann,et al.  Clonal Expansions of Cd8+ T Cells Dominate the T Cell Infiltrate in Active Multiple Sclerosis Lesions as Shown by Micromanipulation and Single Cell Polymerase Chain Reaction , 2000, The Journal of experimental medicine.

[35]  M. Raff,et al.  Basic helix-loop-helix proteins and the timing of oligodendrocyte differentiation. , 2000, Development.

[36]  H. Lassmann,et al.  Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions. , 2000, The American journal of pathology.

[37]  J. Parisi,et al.  Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination , 2000, Annals of neurology.

[38]  S. Sakoda,et al.  Morphometric analysis of the myelin-associated oligodendrocytic basic protein-deficient mouse reveals a possible role for myelin-associated oligodendrocytic basic protein in regulating axonal diameter , 2000, Neuroscience.

[39]  W. Brück,et al.  Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation. , 2000, Brain : a journal of neurology.

[40]  M W Weiner,et al.  1H MRSI comparison of white matter and lesions in primary progressive and relapsing-remitting MS , 2000, Multiple sclerosis.

[41]  Nikos Evangelou,et al.  Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis , 2000, Annals of neurology.

[42]  M Filippi,et al.  A magnetization transfer histogram study of normal-appearing brain tissue in MS , 2000, Neurology.

[43]  B. Scheithauer,et al.  A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases. , 1999, Brain : a journal of neurology.

[44]  W. Poewe,et al.  Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study. , 1999, Brain : a journal of neurology.

[45]  F. Barkhof,et al.  Axonal loss in multiple sclerosis lesions: Magnetic resonance imaging insights into substrates of disability , 1999, Annals of neurology.

[46]  G. Barker,et al.  Magnetisation transfer of normal appearing white matter in primary progressive multiple sclerosis , 1999, Multiple sclerosis.

[47]  H. Lassmann,et al.  Axonal Pathology in Multiple Sclerosis. A Historical Note , 1999, Brain pathology.

[48]  F. Lublin,et al.  The genetics of multiple sclerosis. A review. , 1999, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[49]  P C O'Brien,et al.  The clinical course of neuromyelitis optica (Devic’s syndrome) , 1999, Neurology.

[50]  J. Uhm,et al.  Migratory behavior of lymphocytes isolated from multiple sclerosis patients: Effects of interferon β‐1b therapy , 1999, Annals of neurology.

[51]  A. Compston,et al.  Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis , 1999, Annals of neurology.

[52]  R. Hohlfeld.  Immuntherapie der Multiplen Sklerose Konsens und Kontroversen , 1999, Der Nervenarzt.

[53]  Jakob S. Jensen,et al.  Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. , 1999, The Journal of clinical investigation.

[54]  Hans Lassmann,et al.  Activated Human T Cells, B Cells, and Monocytes Produce Brain-derived Neurotrophic Factor In Vitro and in Inflammatory Brain Lesions: A Neuroprotective Role of Inflammation? , 1999, The Journal of experimental medicine.

[55]  S. Hauser,et al.  Identification of autoantibodies associated with myelin damage in multiple sclerosis , 1999, Nature Medicine.

[56]  M. Pender,et al.  Increased circulating antiganglioside antibodies in primary and secondary progressive multiple sclerosis , 1998, Annals of neurology.

[57]  Moses Rodriguez,et al.  Perforin-Dependent Neurologic Injury in a Viral Model of Multiple Sclerosis , 1998, The Journal of Neuroscience.

[58]  O. Stuve,et al.  Interferon beta in the treatment of multiple sclerosis , 1998, Neurology.

[59]  B. Weinshenker,et al.  ACUTE LEUKOENCEPHALOPATHIES: DIFFERENTIAL DIAGNOSIS AND INVESTIGATION , 1998 .

[60]  F. Barkhof,et al.  Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis , 1998, Neurology.

[61]  H. Lassmann,et al.  Multiple sclerosis: In situ evidence for antibody‐ and complement‐mediated demyelination , 1998, Annals of neurology.

[62]  J. Antel,et al.  MHC class I-restricted lysis of human oligodendrocytes by myelin basic protein peptide-specific CD8 T lymphocytes. , 1998, Journal of immunology.

[63]  M. Cuzner,et al.  Macrophages in CNS Remyelination: Friend or Foe? , 1998, Neurochemical Research.

[64]  Moses Rodriguez,et al.  Absence of neurological deficits following extensive demyelination in a class I-deficient murine model of multiple sclerosis , 1998, Nature Medicine.

[65]  R. Rudick,et al.  Axonal transection in the lesions of multiple sclerosis. , 1998, The New England journal of medicine.

[66]  G. Wolswijk.  Chronic Stage Multiple Sclerosis Lesions Contain a Relatively Quiescent Population of Oligodendrocyte Precursor Cells , 1998, The Journal of Neuroscience.

[67]  G. Barker,et al.  1H magnetic resonance spectroscopy of chronic cerebral white matter lesions and normal appearing white matter in multiple sclerosis , 1997, Journal of neurology, neurosurgery, and psychiatry.

[68]  Hans Lassmann,et al.  Inflammatory central nervous system demyelination: Correlation of magnetic resonance imaging findings with lesion pathology , 1997, Annals of neurology.

[69]  S. Romagnani,et al.  The Th1/Th2 paradigm. , 1997, Immunology today.

[70]  V. Perry,et al.  Axonal damage in acute multiple sclerosis lesions. , 1997, Brain : a journal of neurology.

[71]  S. Hauser,et al.  Late Complications of Immune Deviation Therapy in a Nonhuman Primate , 1996, Science.

[72]  F. Barkhof,et al.  Accumulation of hypointense lesions ("black holes") on T1 spin-echo MRI correlates with disease progression in multiple sclerosis , 1996, Neurology.

[73]  A J Thompson,et al.  Progressive cerebral atrophy in multiple sclerosis. A serial MRI study. , 1996, Brain : a journal of neurology.

[74]  L. Ro,et al.  Serial MRI studies in pathologically verified Balò's concentric sclerosis. , 1996, Journal of computer assisted tomography.

[75]  H. Link,et al.  Review: cytokines and the pathogenesis of multiple sclerosis , 1996, Journal of neuroscience research.

[76]  J. Bilbao,et al.  Acute multiple sclerosis (marburg type) is associated with developmentally immature myelin basic protein , 1996, Annals of neurology.

[77]  J. Masdeu,et al.  The Open Ring A New Imaging Sign in Demyelinating Disease , 1996, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[78]  A. Aruffo,et al.  CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[79]  F. Lublin,et al.  Management of patients receiving interferon beta-1b for multiple sclerosis , 1996, Neurology.

[80]  G. Kollias,et al.  Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor alpha. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[81]  Hans Lassmann,et al.  Monocyte/macrophage differentiation in early multiple sclerosis lesions , 1995, Annals of neurology.

[82]  G. Comi,et al.  A brain MRI study of different types of chronic‐progressive multiple sclerosis , 1995, Acta neurologica Scandinavica.

[83]  C. Raine,et al.  The adhesion molecule and cytokine profile of multiple sclerosis lesions , 1995, Annals of neurology.

[84]  K. Jellinger,et al.  Patterns of oligodendroglia pathology in multiple sclerosis. , 1994, Brain : a journal of neurology.

[85]  J. Wondergem,et al.  Baló concentric sclerosis: MR diagnosis. , 1994, AJNR. American journal of neuroradiology.

[86]  G. H. Collins,et al.  Antemortem diagnosis of Baló concentric sclerosis: correlative MR imaging and pathologic features. , 1994, Radiology.

[87]  W. Brück,et al.  Oligodendrocytes in the early course of multiple sclerosis , 1994, Annals of neurology.

[88]  P Brugières,et al.  Concentric MR patterns in multiple sclerosis. Report of two cases. , 1993, Journal of neuroradiology. Journal de neuroradiologie.

[89]  T Revesz,et al.  Multiple sclerosis. Pathology of recurrent lesions. , 1993, Brain : a journal of neurology.

[90]  J. Kepes,et al.  Large focal tumor‐like demyelinating lesions of the brain: Intermediate entity between multiple sclerosis and acute disseminated encephalomyelitis? A study of 31 patients , 1993, Annals of neurology.

[91]  S. Reingold,et al.  Revised estimate of the prevalence of multiple sclerosis in the united states , 1992, Annals of neurology.

[92]  W. Mcdonald,et al.  The longstanding MS lesion. A quantitative MRI and electron microscopic study. , 1991, Brain : a journal of neurology.

[93]  L. Kappos,et al.  MRI study of Baló's concentric sclerosis before and after immunosuppressive therapy , 1989, Journal of Neurology.

[94]  M. Norenberg,et al.  Multiple sclerosis‐like illness occurring with human immunodeficiency virus infection , 1989, Neurology.

[95]  H. Lassmann,et al.  Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein. , 1988, The American journal of pathology.

[96]  E. Alvord,et al.  Balo's concentric demyelination diagnosed premortem , 1986, Neurology.

[97]  J. Coligan,et al.  Is β2-microglobulin required for MHC class I heavy chain expression? , 1985, Immunology today.

[98]  N. J. Pressman,et al.  A quantitation of myelin‐associated glycoprotein and myelin basic protein loss in different demyelinating disease , 1985, Annals of neurology.

[99]  M. Rodriguez.  Virus-induced demyelination in mice: "dying back" of oligodendrocytes. , 1985, Mayo Clinic proceedings.

[100]  S. DeArmond,et al.  91 AN ELISA AND TRANSBLOT STUDY OF GFAP IN HEPATIC ENCEPHALOPATHY , 1984 .

[101]  Y. Kuroiwa.  Clinical and epidemiological aspects of multiple sclerosis in Japan. , 1982, Japanese journal of medicine.

[102]  Y. Itoyama,et al.  Distribution of papovavirus, myelin‐associated glycoprotein, and myelin basic protein in progressive multifocal leukoencephalopathy lesions , 1982, Annals of neurology.

[103]  L. Scheinberg,et al.  Multiple sclerosis. Oligodendrocyte survival and proliferation in an active established lesion. , 1981, Laboratory investigation; a journal of technical methods and pathology.

[104]  J. Prineas,et al.  Multiple sclerosis: Capping of surface immunoglobulin G on macrophages engaged in myelin breakdown , 1981, Annals of neurology.

[105]  Y. Itoyama,et al.  Immunocytochemical observations on the distribution of myelin‐associated glycoprotein and myelin basic protein in multiple sclerosis lesions , 1980, Annals of neurology.

[106]  G. Reifenberger,et al.  Balo's concentric sclerosis followed by MRI and positron emission tomography , 2004, Neuroradiology.

[107]  C R Guttmann,et al.  A longitudinal study of callosal atrophy and interhemispheric dysfunction in relapsing-remitting multiple sclerosis. , 2001, Archives of neurology.

[108]  F. Barkhof,et al.  Cortical lesions in multiple sclerosis. , 1999, Brain : a journal of neurology.

[109]  Irun R. Cohen,et al.  Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy , 1999, Nature Medicine.

[110]  B. Scheithauer,et al.  Ultrastructure of multiple sclerosis. , 1994, Ultrastructural pathology.

[111]  R. Stocker,et al.  Selective degeneration of oligodendrocytes mediated by reactive oxygen species. , 1990, Free radical research communications.

[112]  J. Cruveilhier.  Anatomie pathologique du corps humain , 1829 .